Drug Database
Back to search

Netherlands· NL-7030dab1641c

Enzalutamide 1A Pharma 160 mg, filmomhulde tabletten

A enzalutamide product containing enzalutamide, registered in Netherlands by 1A Pharma GmbH. The same ATC class is registered in 16 of our 19 countries.

ATC L02BB04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedEnzalutamide 1A Pharma 160 mg, filmom…ATCL02BB04REGISTER NO.NL-7030dab1641cPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about enzalutamideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Enzalutamide is registered in 16 of 19 countries.

Countries holding a registration under ATC L02BB04 (enzalutamide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search enzalutamide products by name

Enzalutamide · ATC L02BB04

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of enzalutamide costs, country by country.

Normalised to the WHO defined daily dose (0.16 g), the median price runs from $0.46 in France to $135.12 in Switzerland — a ×295 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Enzalutamide · price per daily dose (0.16 g)

USD · FX 28 Sept 2026

  • CH Switzerland$135.12
  • FR France$0.46
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ENZALUTAMIDE
Manufacturer
1A Pharma GmbH
Country
Netherlands (NL)
ATC code
L02BB04
ATC class
Enzalutamide
Defined daily dose
0.16 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    133988

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

706 interactions on record for enzalutamide.

Graded by severity as the source publishes them — 241 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check enzalutamide against other medicinesHow interaction checks work

Enzalutamide · interactions on record

706 records

  • 241 severe
  • 448 moderate
  • 17 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • RolapitantA04AD14severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Enzalutamide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All enzalutamide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Englabloc, Enzalutamid 1a Pharma
  • Belgium · Enzalutamide Accord, Enzalutamide Eg
  • Bulgaria · Ензалутамид Sdz, Ензалутамид Сандоз
  • Cyprus · Enzalutamide Accord, Enzalutamide Ebewe
  • Czechia · Enzalutamid Sandoz S.R.O., Enzalutamid Stada
  • Germany · Enzalutamid Accord, Enzalutamid Al
  • Denmark · Enzalutamide "sandoz", Enzalutamide Hexal
  • Estonia · Enzalutamide Accord, Enzalutamide Norameda
  • Spain · Enzalutamida Accord, Enzalutamida Sandoz
  • Finland · Enzalutamide 1a Farma, Enzalutamide Adalvo
  • France · Enzalutamide Accord, Enzalutamide Biogaran
  • United Kingdom (Northern Ireland) · Enzalutamide Accord Healthcare, Enzalutamide Genus Pharmaceuticals
  • Greece · Enzalutamide Accord, Enzalutamide Anabiosis
  • Croatia · Enzalutamid Accord, Enzalutamid Pharmascience
  • Hungary · Enzalutamid 1 A Pharma, Enzalutamid Sandoz
  • Ireland · Enzalutamide Accord, Enzalutamide Clonmel
  • Iceland · Enzalutamide Accordpharma, Enzalutamide Hexal
  • Italy · Enzalutamide Accord, Enzalutamide Eg
  • Liechtenstein · Enzalutamide Accordpharma, Enzalutamide Viatris
  • Lithuania · Enzalutamide Accord, Enzalutamide Hexal
  • Luxembourg · Enzalutamide Eg
  • Latvia · Enzalutamide Accord, Enzalutamide Hexal
  • Malta · Enzalutamid Pharos, Enzalutamide
  • Norway · Enzalutamide Accord, Enzalutamide Accordpharma
  • Poland · Enzalutamid Sandoz, Enzalutamide
  • Portugal · Enzalutamida Stada, Enzalutamida Stada 40 Mg Comprimidos Revestidos Por Película
  • Romania · Enzalutamidă Accord, Enzalutamida Rhei
  • Sweden · Enzalutamid Sun Pharma, Enzalutamide Hexal
  • Slovenia · Enzalutamid Sandoz, Enzalutamid Sandoz Gmbh
  • Slovakia · Englabloc, Enzalutamid Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/301a8819-1f12-4fdc-aa64-2afc47afb4b9
GET /v1/drugs/301a8819-1f12-4fdc-aa64-2afc47afb4b9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h133988_smpc_en.pdf",
  "strength": null,
  "atc_label": "Enzalutamide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg133988",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "COPOLYMEER VAN ETHYLACRYLAAT-METHACRYLZUUR (1:1)",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMLAURILSULFAAT",
    "POLYSORBAAT 80 (E 433)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "ENZALUTAMIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h133988_piluk.pdf",
  "authorised_at": "2025/10/15",
  "procedure_number": "NL/H/5870/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "133988",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about enzalutamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console